Literature DB >> 15200735

The wet patient: understanding patients with overactive bladder and incontinence.

Scott Serels1.   

Abstract

Overactive bladder (OAB) is a constellation of lower urinary tract symptoms, including urinary frequency and urgency,which can occur with or without urinary incontinence. Incontinence is present in over half of female patients with OAB. This condition affects more than 33 million Americans and imposes considerable economic, social, and psychological burdens. Although continued improvements in the pharmacologic management of lower urinary tract disorders have led to the availability of well-tolerated, characteristic features, prevalence and epidemiology, effective treatment options, the symptoms of OAB are generally underreported by patients and under treated by healthcare professionals. Heightened awareness of the multifaceted disease burden imposed by OAB and increased understanding of the characteristics of patients who are likely to be most severely affected, in particular those who suffer from incontinence, may improve the timely identification, diagnosis, and clinical management of the syndrome, enhancing both the health and quality of life of these patients. This review will summarize the clinical consequences, and management of OAB, with particular focus on the incontinent patient.

Entities:  

Mesh:

Year:  2004        PMID: 15200735     DOI: 10.1185/030079904125003593

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  4 in total

1.  Rehabilitation vs drug therapy for urge urinary incontinence: short-term outcome.

Authors:  Rachel Kafri; Rami Langer; Zeevi Dvir; Michal Katz-Leurer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-11

2.  Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder.

Authors:  Franklin Chu; Neila Smith; Takeshi Uchida
Journal:  Curr Ther Res Clin Exp       Date:  2009-12

Review 3.  Social, economic, and health utility considerations in the treatment of overactive bladder.

Authors:  Emilio Sacco; Daniele Tienforti; Alessandro D'Addessi; Francesco Pinto; Marco Racioppi; Angelo Totaro; Daniele D'Agostino; Francesco Marangi; Pierfrancesco Bassi
Journal:  Open Access J Urol       Date:  2010-02-11

4.  Alterations of the myovesical plexus of the human overactive detrusor.

Authors:  Kamiel A J Kuijpers; John P F A Heesakkers; Jack A Schalken
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.